IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab
Clinical trial NCT03340610 · COMPLETED
Trial details
- NCT number
- NCT03340610
- Sponsor
- Southeast Retina Center, Georgia
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2018-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.